Suchergebnisse - "*Ritonavir"

PubPharm (2.149)

1

Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Singh, R. | LaBadie, R. | Toussi, S. | +4

2

Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China : a multicentre, retrospective cohort study

enthalten in: Annals of medicine | 2024

von Han, X. | Li, C. | Yuan, X. | +22

3

Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro

enthalten in: Antiviral research | 2024

von Gallucci, L. | Bazire, J. | Davidson, A. | +1

4

No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

enthalten in: Journal of medical virology | 2024

von Palomino-Cabrera, R. | Tejerina, F. | Molero-Salinas, A. | +9

5

PBPK Modeling of PAXLOVIDTM : Incorporating Rotamer Conversion Kinetics to Advanced Dissolution and Absorption Model

enthalten in: Journal of pharmaceutical sciences | 2024

von Jaini, R. | Lin, J. | Di, L. | +1

6

Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults

enthalten in: British journal of clinical pharmacology | 2024

von Zhang, Y. | Joshi, S. | Yazdani, P. | +6

7

Association Between Paxlovid and Mortality Rates in Critically Ill Patients With COVID-19 Receiving Invasive Mechanical Ventilation : A Retrospective Cohort Study

enthalten in: Chest | 2024

von Yang, M. | Jiang, L. | Xu, L. | +1

8

Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study

enthalten in: Journal of medical virology | 2024

von Durstenfeld, M. | Peluso, M. | Lin, F. | +10

9

Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk

enthalten in: The Journal of infectious diseases | 2023

von Paraskevis, D. | Gkova, M. | Mellou, K. | +16

10

Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19 : Emulation of a randomized target trial

enthalten in: Journal of medical virology | 2023

von Zhou, Y. | Liu, Y. | Jiang, L. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[215]